Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 904-915 |
| Number of pages | 12 |
| Journal | Endoscopy |
| Volume | 54 |
| Issue number | 9 |
| Early online date | 2022 |
| DOIs | |
| Publication status | Published - 25 Aug 2022 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Endoscopy, Vol. 54, No. 9, 25.08.2022, p. 904-915.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Performance measures for colonoscopy in inflammatory bowel disease patients
T2 - European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
AU - Dekker, Evelien
AU - Nass, Karlijn J.
AU - Iacucci, Marietta
AU - Murino, Alberto
AU - Sabino, João
AU - Bugajski, Marek
AU - Carretero, Cristina
AU - Cortas, George
AU - Despott, Edward J.
AU - East, James E.
AU - Kaminski, Michal F.
AU - Karstensen, John G. sdal
AU - Keuchel, Martin
AU - Löwenberg, Mark
AU - Monged, Ashraf
AU - Nardone, Olga M.
AU - Neumann, Helmut
AU - Omar, Mahmoud M.
AU - Pellisé, Maria
AU - Peyrin-Biroulet, Laurent
AU - Rutter, Matthew D.
AU - Bisschops, Raf
N1 - Funding Information: R. Bisschops has received research grants and speaker’s fees from Fujifilm, Norgine, and Pentax; he has provided consultancy for Fujifilm, Norgine, and Pentax. E. Dekker has received a research grant and has endoscopic equipment on loan from Fujifilm; she has received speakerʼs fees from Olympus, GI Supply, Norgine, Ipsen, Paion, and Fujifilm; she has provided consultancy for Fujifilm, Olympus, GI Supply, Paion, and Ambu. J.E. East has received speaker’s fees from Falk and Jenssen, has served on clinical advisory boards for Paion, and has served on the clinical advisory board and has share options in Satisfai Health. M. Iacucci has received research grants from Olympus, Pentax, and Fujifilm. M.F. Kaminski has equipment on loan from Fujifilm; he has received speaker’s fees from Boston Scientific, Ipsen, and Recordati, and a research grant from Olympus; he has provided consultancy for Olympus and ERBE. J.G. Karstensen has received speaker’s fees from Norgine and provided for consultancy from Ambu and SNIPR Biome. M. Keuchel has received speaker’s fees from Medtronic and Olympus, and study support from AnXRobotics; he has provided consultancy for Medtronic. M. Pellisé has provided consultancy to Norgine Iberia, GI Supply, and Fujifilm; she has served on the editorial board of Thieme, has been the ESGE equity and diversity working group chair and a councillor for SEED, and is president elect of AEG; her department has received research support from Fujifilm and Casen Recordat. L. Peyrin-Biroulet has received personal fees from Abbvie, Janssen, Takeda, and Celltrion. None of the above conflicts of interest are of relevance to this manuscript. M. Bugajski, C. Carretero, G. Cortas, E.J. Despott, M. Löwenberg, A. Monged, A. Murino, K.J. Nass, O.M. Nardone, H. Neumann, M. Omar, and M.D. Rutter declare that they have no conflict of interest. Funding Information: In an endoscopically completely normal colon, biopsies are also important to rule out microscopic colitis. Here, ESGE recommends two biopsies from the left colon and two biopsies from the right colon, placed in separate containers and labelled as such . This is supported by the finding of lymphocytic and collagenous colitis presenting histologically as pancolitis, excluding the rectum . Publisher Copyright: © 2022 Georg Thieme Verlag. All rights reserved.
PY - 2022/8/25
Y1 - 2022/8/25
N2 - The European Society of Gastrointestinal Endoscopy (ESGE) presents a short list of performance measures for colonoscopy in inflammatory bowel disease (IBD) patients. Current performance measures for colonoscopy mainly focus on detecting (pre)malignant lesions. However, these performance measures are not relevant for all colonoscopy indications in IBD patients. Therefore, our aim was to provide endoscopy services across Europe and other interested countries with a tool for quality monitoring and improvement in IBD colonoscopy. Eight key performance measures and one minor performance measure were recommended for measurement and evaluation in daily endoscopy practice.
AB - The European Society of Gastrointestinal Endoscopy (ESGE) presents a short list of performance measures for colonoscopy in inflammatory bowel disease (IBD) patients. Current performance measures for colonoscopy mainly focus on detecting (pre)malignant lesions. However, these performance measures are not relevant for all colonoscopy indications in IBD patients. Therefore, our aim was to provide endoscopy services across Europe and other interested countries with a tool for quality monitoring and improvement in IBD colonoscopy. Eight key performance measures and one minor performance measure were recommended for measurement and evaluation in daily endoscopy practice.
UR - http://www.scopus.com/inward/record.url?scp=85135753073&partnerID=8YFLogxK
U2 - https://doi.org/10.1055/a-1874-0946
DO - https://doi.org/10.1055/a-1874-0946
M3 - Article
C2 - 35913069
SN - 0013-726X
VL - 54
SP - 904
EP - 915
JO - Endoscopy
JF - Endoscopy
IS - 9
ER -